The occurrence of facultative paedomorphosis in a lacustrine population of the Pyrenean newt (Calotriton asper): morphology and age structure

Facultative paedomorphosis is a common polyphenism in newts where two alternative phenotypes can coexist: metamorphs and paedomorphs (mature with larval traits, i.e. retaining gills). This phenomenon has been reported in some lacustrine populations of the Pyrenean newt (Calotriton asper). The morphology and life-history traits were studied in a lacustrine population of this species with the occurrence of facultative paedomorphosis. The results showed that 24.3% of adults retained gills at different levels of reabsorption and had a smoother skin compared with the other populations, which were fully metamorphic. The body size and shape showed significant sexual differences, with males being larger than females. The presence of paedomorphic traits also affected the body size and shape, revealing a complex pattern of growth in which metamorphic adults were larger than paedomorphs. The age structure was different between sexes, with a median age of 10.5 and 7 years and longevity of 19 and 14 years in males and females, respectively. Considering each sex separately, the age structure was not significantly different between metamorphic and paedomorphic newts. In addition, metamorphosed and branchiate juveniles were found with a maximum age of 13 and 20 years, respectively. Remarkably, long-lived larvae with an exceptional individual of 18 years were found, which has not previously been reported in any other newt species. The mechanisms that can explain the evolution of paedomorphosis are complex and comprise the interaction of multiple factors related to the cost of reproduction and growth.     

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

Here we perform whole-exome sequencing of samples from 105 individuals with chronic lymphocytic leukemia (CLL), the most frequent leukemia in adults in Western countries. We found 1,246 somatic mutations potentially affecting gene function and identified 78 genes with predicted functional alterations in more than one tumor sample. Among these genes, SF3B1, encoding a subunit of the spliceosomal U2 small nuclear ribonucleoprotein (snRNP), is somatically mutated in 9.7% of affected individuals. Further analysis in 279 individuals with CLL showed that SF3B1 mutations were associated with faster disease progression and poor overall survival. This work provides the first comprehensive catalog of somatic mutations in CLL with relevant clinical correlates and defines a large set of new genes that may drive the development of this common form of leukemia. The results reinforce the idea that targeting several well-known genetic pathways, including mRNA splicing, could be useful in the treatment of CLL and other malignancies.     

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

Chronic lymphocytic leukaemia (CLL), the most frequent leukaemia in adults in Western countries, is a heterogeneous disease with variable clinical presentation and evolution. Two major molecular subtypes can be distinguished, characterized respectively by a high or low number of somatic hypermutations in the variable region of immunoglobulin genes. The molecular changes leading to the pathogenesis of the disease are still poorly understood. Here we performed whole-genome sequencing of four cases of CLL and identified 46 somatic mutations that potentially affect gene function. Further analysis of these mutations in 363 patients with CLL identified four genes that are recurrently mutated: notch 1 (NOTCH1), exportin 1 (XPO1), myeloid differentiation primary response gene 88 (MYD88) and kelch-like 6 (KLHL6). Mutations in MYD88 and KLHL6 are predominant in cases of CLL with mutated immunoglobulin genes, whereas NOTCH1 and XPO1 mutations are mainly detected in patients with unmutated immunoglobulins. The patterns of somatic mutation, supported by functional and clinical analyses, strongly indicate that the recurrent NOTCH1, MYD88 and XPO1 mutations are oncogenic changes that contribute to the clinical evolution of the disease. To our knowledge, this is the first comprehensive analysis of CLL combining whole-genome sequencing with clinical characteristics and clinical outcomes. It highlights the usefulness of this approach for the identification of clinically relevant mutations in cancer.